These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 20010925

  • 1. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P, Reinisch W, Ho E, Gratzer C, Lissner D, Herkner H, Riss S, Dejaco C, Miehsler W, Vogelsang H, Novacek G.
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [Abstract] [Full Text] [Related]

  • 2. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
    Szamosi T, Banai J, Lakatos L, Czegledi Z, David G, Zsigmond F, Pandur T, Erdelyi Z, Gemela O, Papp M, Papp J, Lakatos PL.
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
    [Abstract] [Full Text] [Related]

  • 3. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A, Actis GC, Duca P, Massari A, Colombo E, Gai E, Annese V, D'Albasio G, Manes G, Travis S, Porro GB, Ardizzone S.
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [Abstract] [Full Text] [Related]

  • 4. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease.
    Myrelid P, Svärm S, Andersson P, Almer S, Bodemar G, Olaison G.
    Scand J Gastroenterol; 2006 Oct; 41(10):1190-5. PubMed ID: 16990204
    [Abstract] [Full Text] [Related]

  • 5. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
    Picco MF, Zubiaurre I, Adluni M, Cangemi JR, Shelton D.
    Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
    [Abstract] [Full Text] [Related]

  • 6. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF, Loftus EV, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ.
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [Abstract] [Full Text] [Related]

  • 7. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.
    Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB.
    Gut; 2010 Sep; 59(9):1200-6. PubMed ID: 20650924
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcome of surgically treated Crohn's colitis: a prospective study.
    Fichera A, McCormack R, Rubin MA, Hurst RD, Michelassi F.
    Dis Colon Rectum; 2005 May; 48(5):963-9. PubMed ID: 15785882
    [Abstract] [Full Text] [Related]

  • 9. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
    Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Veres G, Lovasz BD, Szathmari M, Kiss LS, Lakatos L.
    Am J Gastroenterol; 2012 Apr; 107(4):579-88. PubMed ID: 22233693
    [Abstract] [Full Text] [Related]

  • 10. Is there any difference in recurrence rates in laparoscopic ileocolic resection for Crohn's disease compared with conventional surgery? A long-term, follow-up study.
    Lowney JK, Dietz DW, Birnbaum EH, Kodner IJ, Mutch MG, Fleshman JW.
    Dis Colon Rectum; 2006 Jan; 49(1):58-63. PubMed ID: 16328612
    [Abstract] [Full Text] [Related]

  • 11. 6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.
    Almer SH, Hjortswang H, Hindorf U.
    Dig Liver Dis; 2009 Mar; 41(3):194-200. PubMed ID: 18799369
    [Abstract] [Full Text] [Related]

  • 12. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS, Zlatanic J, Korelitz BI, Gleim GW.
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [Abstract] [Full Text] [Related]

  • 13. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
    Oussalah A, Chevaux JB, Fay R, Sandborn WJ, Bigard MA, Peyrin-Biroulet L.
    Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296
    [Abstract] [Full Text] [Related]

  • 14. Repeat intestinal resections increase the risk of recurrence of Crohn's disease.
    Riss S, Schuster I, Papay P, Mittlböck M, Stift A.
    Dis Colon Rectum; 2013 Jul; 56(7):881-7. PubMed ID: 23739195
    [Abstract] [Full Text] [Related]

  • 15. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse.
    Treton X, Bouhnik Y, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Cosnes J, Lemann M, Groupe D'Etude Thérapeutique Des Affections Inflammatoires Du Tube Digestif (GETAID).
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):80-5. PubMed ID: 18849016
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M, Louis-Auguste JR, Baxter LM, Limdi JK, McCartney SA, Lindsay JO, Bloom SL.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):614-20. PubMed ID: 19552632
    [Abstract] [Full Text] [Related]

  • 17. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
    González-Lama Y, Suárez C, González-Partida I, Calvo M, Matallana V, de la Revilla J, Magaz M, Bernardo C, Agudo B, Ibarrola P, Relea L, Arévalo J, Vera MI, Abreu L.
    J Crohns Colitis; 2016 Jan 15; 10(1):55-60. PubMed ID: 26520164
    [Abstract] [Full Text] [Related]

  • 18. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug 15; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 19. The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence.
    Ferrante M, de Hertogh G, Hlavaty T, D'Haens G, Penninckx F, D'Hoore A, Vermeire S, Rutgeerts P, Geboes K, van Assche G.
    Gastroenterology; 2006 May 15; 130(6):1595-606. PubMed ID: 16697723
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G, Israel DM, Hassall E.
    Am J Gastroenterol; 1996 Jul 15; 91(7):1355-9. PubMed ID: 8677994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.